Published in Nat Rev Immunol on January 01, 2004
Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J Exp Med (2006) 2.53
Oncogenic activities of human papillomaviruses. Virus Res (2009) 1.60
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci U S A (2007) 1.53
Viruses associated with human cancer. Biochim Biophys Acta (2007) 1.47
Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol (2010) 1.45
Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles. Virology (2007) 1.29
Cancer associated human papillomaviruses. Curr Opin Virol (2012) 1.25
Papillomavirus E5: the smallest oncoprotein with many functions. Mol Cancer (2011) 1.25
Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia. Eye (Lond) (2011) 1.13
High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract. Immunology (2006) 1.09
Development of therapeutic HPV vaccines. Lancet Oncol (2009) 1.04
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol Oncol (2007) 1.03
Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg (2012) 1.03
Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health (2013) 1.01
A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers. J Biol Chem (2010) 1.00
Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology (2006) 0.98
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clin Exp Immunol (2007) 0.95
Human papillomaviruses as therapeutic targets in human cancer. J Clin Oncol (2011) 0.90
Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers. Iran J Basic Med Sci (2012) 0.89
HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells. PLoS Pathog (2014) 0.88
Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G. Oncol Rep (2011) 0.86
Establishment of a cottontail rabbit papillomavirus/HLA-A2.1 transgenic rabbit model. J Virol (2007) 0.86
Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens. Front Immunol (2011) 0.86
A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin. J Immunol (2012) 0.85
The paradox of IL-10-mediated modulation in cervical cancer. Biomed Rep (2013) 0.85
Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein. Clin Vaccine Immunol (2008) 0.85
Human papillomavirus-associated plantar epidermoid cysts: MR and US imaging appearance. Skeletal Radiol (2013) 0.84
HPVdb: a data mining system for knowledge discovery in human papillomavirus with applications in T cell immunology and vaccinology. Database (Oxford) (2014) 0.84
Tumor prevention in HPV8 transgenic mice by HPV8-E6 DNA vaccination. Med Microbiol Immunol (2014) 0.83
Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study. BMC Infect Dis (2011) 0.82
The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma. Oncoimmunology (2014) 0.82
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil). Ther Clin Risk Manag (2008) 0.81
Cervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in Toll-like receptor profile. Biomed Res Int (2014) 0.81
Biochemical and functional interactions of human papillomavirus proteins with polycomb group proteins. Viruses (2013) 0.81
Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity. PLoS One (2016) 0.80
Viruses and human cancer. Yale J Biol Med (2006) 0.80
A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection. PLoS One (2013) 0.80
Human Papillomavirus Type16- L1 VLP Production in Insect Cells. Iran J Basic Med Sci (2013) 0.80
Production of human papilloma virus type 16 e6 oncoprotein as a recombinant protein in eukaryotic cells. Iran J Cancer Prev (2012) 0.79
Vaccination against a hit-and-run viral cancer. J Gen Virol (2010) 0.79
Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas. Virol J (2008) 0.79
Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev (2011) 0.79
IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review). Oncol Rep (2014) 0.78
Progress in the development of a cervical cancer vaccine. Ther Clin Risk Manag (2006) 0.78
Immune responses in macaques to a prototype recombinant adenovirus live oral human papillomavirus 16 vaccine. Clin Vaccine Immunol (2014) 0.78
Induction of immune responses against human papillomaviruses by hypervariable epitope constructs. Immunology (2004) 0.77
Towards meeting the research needs of Australian cancer consumers. BMC Res Notes (2012) 0.76
Does parents' socio-economic status matter in intentions of vaccinating against human papillomavirus for adolescent daughters? Afr Health Sci (2015) 0.76
Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein. Clin Vaccine Immunol (2007) 0.76
HPV vaccines: Translating immunogenicity into efficacy. Hum Vaccin Immunother (2015) 0.76
Dysregulated expression of long noncoding RNAs in gynecologic cancers. Mol Cancer (2017) 0.75
Dietary exposure to brominated flame retardants and abnormal Pap test results. J Womens Health (Larchmt) (2011) 0.75
A randomized trial of immunotherapy for persistent genital warts. Hum Vaccin Immunother (2012) 0.75
Social values and scientific evidence: the case of the HPV vaccines. Biol Philos (2010) 0.75
Structural and immunological effects of skin cryoablation in a mouse model. PLoS One (2015) 0.75
HPV16-E7-Specific Activated CD8 T Cells in E7 Transgenic Skin and Skin Grafts. Front Immunol (2017) 0.75
Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice. BMC Immunol (2017) 0.75
Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses (2017) 0.75